COVID-19 Impact on Global Electrocompetent Cells Market Size, Status and Forecast 2020-2026

September 2020 | 126 pages | ID: C320C27CE9D7EN
QYResearch

Abstracts

This report focuses on the global Electrocompetent Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Electrocompetent Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Merck KGaA
• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• Promega Corporation
• Beijing TransGen Biotech
• GeneScript Corporation
• Yeastern Biotech
• New England Biolabs
• QIAGEN N.V.
• OriGene Technologies
• Lucigen
• Zymo Research
• Bio-Rad Laboratories
• Bioline
• Delphi Genetics
• IBA GmBH
• Cell Applications
• BioDynamics Laboratory
• Scarab Genomics

Market segment by Type, the product can be split into

• Cloned Competent Cells
• Agrobacterium tumefaciens Competent Cells
• Expression Competent Cells

Market segment by Application, split into

• Subcloning & Routine Cloning
• Phage Display Library Construction
• Toxic/Unstable Dna Cloning
• High-Throughput Cloning
• Protein Expression
• Mutagenesis
• Single-Stranded Dna Production
• Bacmid creation
• Cre-lox recombination (PIR1/PIR2)

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Electrocompetent Cells status, future forecast, growth opportunity, key market and key players.
• To present the Electrocompetent Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Electrocompetent Cells are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Electrocompetent Cells Revenue
1.4 Market Analysis by Type
  1.4.1 Global Electrocompetent Cells Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Cloned Competent Cells
  1.4.3 Agrobacterium tumefaciens Competent Cells
  1.4.4 Expression Competent Cells
1.5 Market by Application
  1.5.1 Global Electrocompetent Cells Market Share by Application: 2020 VS 2026
  1.5.2 Subcloning & Routine Cloning
  1.5.3 Phage Display Library Construction
  1.5.4 Toxic/Unstable Dna Cloning
  1.5.5 High-Throughput Cloning
  1.5.6 Protein Expression
  1.5.7 Mutagenesis
  1.5.8 Single-Stranded Dna Production
  1.5.9 Bacmid creation
  1.5.10 Cre-lox recombination (PIR1/PIR2)
1.6 Coronavirus Disease 2019 (Covid-19): Electrocompetent Cells Industry Impact
  1.6.1 How the Covid-19 is Affecting the Electrocompetent Cells Industry
    1.6.1.1 Electrocompetent Cells Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Electrocompetent Cells Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Electrocompetent Cells Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Electrocompetent Cells Market Perspective (2015-2026)
2.2 Electrocompetent Cells Growth Trends by Regions
  2.2.1 Electrocompetent Cells Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Electrocompetent Cells Historic Market Share by Regions (2015-2020)
  2.2.3 Electrocompetent Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Electrocompetent Cells Market Growth Strategy
  2.3.6 Primary Interviews with Key Electrocompetent Cells Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Electrocompetent Cells Players by Market Size
  3.1.1 Global Top Electrocompetent Cells Players by Revenue (2015-2020)
  3.1.2 Global Electrocompetent Cells Revenue Market Share by Players (2015-2020)
  3.1.3 Global Electrocompetent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Electrocompetent Cells Market Concentration Ratio
  3.2.1 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Electrocompetent Cells Revenue in 2019
3.3 Electrocompetent Cells Key Players Head office and Area Served
3.4 Key Players Electrocompetent Cells Product Solution and Service
3.5 Date of Enter into Electrocompetent Cells Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Electrocompetent Cells Historic Market Size by Type (2015-2020)
4.2 Global Electrocompetent Cells Forecasted Market Size by Type (2021-2026)

5 ELECTROCOMPETENT CELLS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Electrocompetent Cells Market Size by Application (2015-2020)
5.2 Global Electrocompetent Cells Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Electrocompetent Cells Market Size (2015-2020)
6.2 Electrocompetent Cells Key Players in North America (2019-2020)
6.3 North America Electrocompetent Cells Market Size by Type (2015-2020)
6.4 North America Electrocompetent Cells Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Electrocompetent Cells Market Size (2015-2020)
7.2 Electrocompetent Cells Key Players in Europe (2019-2020)
7.3 Europe Electrocompetent Cells Market Size by Type (2015-2020)
7.4 Europe Electrocompetent Cells Market Size by Application (2015-2020)

8 CHINA

8.1 China Electrocompetent Cells Market Size (2015-2020)
8.2 Electrocompetent Cells Key Players in China (2019-2020)
8.3 China Electrocompetent Cells Market Size by Type (2015-2020)
8.4 China Electrocompetent Cells Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Electrocompetent Cells Market Size (2015-2020)
9.2 Electrocompetent Cells Key Players in Japan (2019-2020)
9.3 Japan Electrocompetent Cells Market Size by Type (2015-2020)
9.4 Japan Electrocompetent Cells Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Electrocompetent Cells Market Size (2015-2020)
10.2 Electrocompetent Cells Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Electrocompetent Cells Market Size by Type (2015-2020)
10.4 Southeast Asia Electrocompetent Cells Market Size by Application (2015-2020)

11 INDIA

11.1 India Electrocompetent Cells Market Size (2015-2020)
11.2 Electrocompetent Cells Key Players in India (2019-2020)
11.3 India Electrocompetent Cells Market Size by Type (2015-2020)
11.4 India Electrocompetent Cells Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Electrocompetent Cells Market Size (2015-2020)
12.2 Electrocompetent Cells Key Players in Central & South America (2019-2020)
12.3 Central & South America Electrocompetent Cells Market Size by Type (2015-2020)
12.4 Central & South America Electrocompetent Cells Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Merck KGaA
  13.1.1 Merck KGaA Company Details
  13.1.2 Merck KGaA Business Overview and Its Total Revenue
  13.1.3 Merck KGaA Electrocompetent Cells Introduction
  13.1.4 Merck KGaA Revenue in Electrocompetent Cells Business (2015-2020))
  13.1.5 Merck KGaA Recent Development
13.2 Thermo Fisher Scientific
  13.2.1 Thermo Fisher Scientific Company Details
  13.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  13.2.3 Thermo Fisher Scientific Electrocompetent Cells Introduction
  13.2.4 Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2015-2020)
  13.2.5 Thermo Fisher Scientific Recent Development
13.3 Agilent Technologies
  13.3.1 Agilent Technologies Company Details
  13.3.2 Agilent Technologies Business Overview and Its Total Revenue
  13.3.3 Agilent Technologies Electrocompetent Cells Introduction
  13.3.4 Agilent Technologies Revenue in Electrocompetent Cells Business (2015-2020)
  13.3.5 Agilent Technologies Recent Development
13.4 Takara Bio
  13.4.1 Takara Bio Company Details
  13.4.2 Takara Bio Business Overview and Its Total Revenue
  13.4.3 Takara Bio Electrocompetent Cells Introduction
  13.4.4 Takara Bio Revenue in Electrocompetent Cells Business (2015-2020)
  13.4.5 Takara Bio Recent Development
13.5 Promega Corporation
  13.5.1 Promega Corporation Company Details
  13.5.2 Promega Corporation Business Overview and Its Total Revenue
  13.5.3 Promega Corporation Electrocompetent Cells Introduction
  13.5.4 Promega Corporation Revenue in Electrocompetent Cells Business (2015-2020)
  13.5.5 Promega Corporation Recent Development
13.6 Beijing TransGen Biotech
  13.6.1 Beijing TransGen Biotech Company Details
  13.6.2 Beijing TransGen Biotech Business Overview and Its Total Revenue
  13.6.3 Beijing TransGen Biotech Electrocompetent Cells Introduction
  13.6.4 Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2015-2020)
  13.6.5 Beijing TransGen Biotech Recent Development
13.7 GeneScript Corporation
  13.7.1 GeneScript Corporation Company Details
  13.7.2 GeneScript Corporation Business Overview and Its Total Revenue
  13.7.3 GeneScript Corporation Electrocompetent Cells Introduction
  13.7.4 GeneScript Corporation Revenue in Electrocompetent Cells Business (2015-2020)
  13.7.5 GeneScript Corporation Recent Development
13.8 Yeastern Biotech
  13.8.1 Yeastern Biotech Company Details
  13.8.2 Yeastern Biotech Business Overview and Its Total Revenue
  13.8.3 Yeastern Biotech Electrocompetent Cells Introduction
  13.8.4 Yeastern Biotech Revenue in Electrocompetent Cells Business (2015-2020)
  13.8.5 Yeastern Biotech Recent Development
13.9 New England Biolabs
  13.9.1 New England Biolabs Company Details
  13.9.2 New England Biolabs Business Overview and Its Total Revenue
  13.9.3 New England Biolabs Electrocompetent Cells Introduction
  13.9.4 New England Biolabs Revenue in Electrocompetent Cells Business (2015-2020)
  13.9.5 New England Biolabs Recent Development
13.10 QIAGEN N.V.
  13.10.1 QIAGEN N.V. Company Details
  13.10.2 QIAGEN N.V. Business Overview and Its Total Revenue
  13.10.3 QIAGEN N.V. Electrocompetent Cells Introduction
  13.10.4 QIAGEN N.V. Revenue in Electrocompetent Cells Business (2015-2020)
  13.10.5 QIAGEN N.V. Recent Development
13.11 OriGene Technologies
  10.11.1 OriGene Technologies Company Details
  10.11.2 OriGene Technologies Business Overview and Its Total Revenue
  10.11.3 OriGene Technologies Electrocompetent Cells Introduction
  10.11.4 OriGene Technologies Revenue in Electrocompetent Cells Business (2015-2020)
  10.11.5 OriGene Technologies Recent Development
13.12 Lucigen
  10.12.1 Lucigen Company Details
  10.12.2 Lucigen Business Overview and Its Total Revenue
  10.12.3 Lucigen Electrocompetent Cells Introduction
  10.12.4 Lucigen Revenue in Electrocompetent Cells Business (2015-2020)
  10.12.5 Lucigen Recent Development
13.13 Zymo Research
  10.13.1 Zymo Research Company Details
  10.13.2 Zymo Research Business Overview and Its Total Revenue
  10.13.3 Zymo Research Electrocompetent Cells Introduction
  10.13.4 Zymo Research Revenue in Electrocompetent Cells Business (2015-2020)
  10.13.5 Zymo Research Recent Development
13.14 Bio-Rad Laboratories
  10.14.1 Bio-Rad Laboratories Company Details
  10.14.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  10.14.3 Bio-Rad Laboratories Electrocompetent Cells Introduction
  10.14.4 Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2015-2020)
  10.14.5 Bio-Rad Laboratories Recent Development
13.15 Bioline
  10.15.1 Bioline Company Details
  10.15.2 Bioline Business Overview and Its Total Revenue
  10.15.3 Bioline Electrocompetent Cells Introduction
  10.15.4 Bioline Revenue in Electrocompetent Cells Business (2015-2020)
  10.15.5 Bioline Recent Development
13.16 Delphi Genetics
  10.16.1 Delphi Genetics Company Details
  10.16.2 Delphi Genetics Business Overview and Its Total Revenue
  10.16.3 Delphi Genetics Electrocompetent Cells Introduction
  10.16.4 Delphi Genetics Revenue in Electrocompetent Cells Business (2015-2020)
  10.16.5 Delphi Genetics Recent Development
13.17 IBA GmBH
  10.17.1 IBA GmBH Company Details
  10.17.2 IBA GmBH Business Overview and Its Total Revenue
  10.17.3 IBA GmBH Electrocompetent Cells Introduction
  10.17.4 IBA GmBH Revenue in Electrocompetent Cells Business (2015-2020)
  10.17.5 IBA GmBH Recent Development
13.18 Cell Applications
  10.18.1 Cell Applications Company Details
  10.18.2 Cell Applications Business Overview and Its Total Revenue
  10.18.3 Cell Applications Electrocompetent Cells Introduction
  10.18.4 Cell Applications Revenue in Electrocompetent Cells Business (2015-2020)
  10.18.5 Cell Applications Recent Development
13.19 BioDynamics Laboratory
  10.19.1 BioDynamics Laboratory Company Details
  10.19.2 BioDynamics Laboratory Business Overview and Its Total Revenue
  10.19.3 BioDynamics Laboratory Electrocompetent Cells Introduction
  10.19.4 BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2015-2020)
  10.19.5 BioDynamics Laboratory Recent Development
13.20 Scarab Genomics
  10.20.1 Scarab Genomics Company Details
  10.20.2 Scarab Genomics Business Overview and Its Total Revenue
  10.20.3 Scarab Genomics Electrocompetent Cells Introduction
  10.20.4 Scarab Genomics Revenue in Electrocompetent Cells Business (2015-2020)
  10.20.5 Scarab Genomics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Electrocompetent Cells Key Market Segments
Table 2. Key Players Covered: Ranking by Electrocompetent Cells Revenue
Table 3. Ranking of Global Top Electrocompetent Cells Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Electrocompetent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cloned Competent Cells
Table 6. Key Players of Agrobacterium tumefaciens Competent Cells
Table 7. Key Players of Expression Competent Cells
Table 8. COVID-19 Impact Global Market: (Four Electrocompetent Cells Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Electrocompetent Cells Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Electrocompetent Cells Players to Combat Covid-19 Impact
Table 13. Global Electrocompetent Cells Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Electrocompetent Cells Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Electrocompetent Cells Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Electrocompetent Cells Market Share by Regions (2015-2020)
Table 17. Global Electrocompetent Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Electrocompetent Cells Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Electrocompetent Cells Market Growth Strategy
Table 23. Main Points Interviewed from Key Electrocompetent Cells Players
Table 24. Global Electrocompetent Cells Revenue by Players (2015-2020) (Million US$)
Table 25. Global Electrocompetent Cells Market Share by Players (2015-2020)
Table 26. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Electrocompetent Cells as of 2019)
Table 27. Global Electrocompetent Cells by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Electrocompetent Cells Product Solution and Service
Table 30. Date of Enter into Electrocompetent Cells Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 33. Global Electrocompetent Cells Market Size Share by Type (2015-2020)
Table 34. Global Electrocompetent Cells Revenue Market Share by Type (2021-2026)
Table 35. Global Electrocompetent Cells Market Size Share by Application (2015-2020)
Table 36. Global Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 37. Global Electrocompetent Cells Market Size Share by Application (2021-2026)
Table 38. North America Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Electrocompetent Cells Market Share (2019-2020)
Table 40. North America Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 41. North America Electrocompetent Cells Market Share by Type (2015-2020)
Table 42. North America Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 43. North America Electrocompetent Cells Market Share by Application (2015-2020)
Table 44. Europe Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Electrocompetent Cells Market Share (2019-2020)
Table 46. Europe Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Electrocompetent Cells Market Share by Type (2015-2020)
Table 48. Europe Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Electrocompetent Cells Market Share by Application (2015-2020)
Table 50. China Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 51. China Key Players Electrocompetent Cells Market Share (2019-2020)
Table 52. China Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 53. China Electrocompetent Cells Market Share by Type (2015-2020)
Table 54. China Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 55. China Electrocompetent Cells Market Share by Application (2015-2020)
Table 56. Japan Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Electrocompetent Cells Market Share (2019-2020)
Table 58. Japan Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Electrocompetent Cells Market Share by Type (2015-2020)
Table 60. Japan Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Electrocompetent Cells Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Electrocompetent Cells Market Share (2019-2020)
Table 64. Southeast Asia Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Electrocompetent Cells Market Share by Type (2015-2020)
Table 66. Southeast Asia Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Electrocompetent Cells Market Share by Application (2015-2020)
Table 68. India Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 69. India Key Players Electrocompetent Cells Market Share (2019-2020)
Table 70. India Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 71. India Electrocompetent Cells Market Share by Type (2015-2020)
Table 72. India Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 73. India Electrocompetent Cells Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Electrocompetent Cells Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Electrocompetent Cells Market Share (2019-2020)
Table 76. Central & South America Electrocompetent Cells Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Electrocompetent Cells Market Share by Type (2015-2020)
Table 78. Central & South America Electrocompetent Cells Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Electrocompetent Cells Market Share by Application (2015-2020)
Table 80. Merck KGaA Company Details
Table 81. Merck KGaA Business Overview
Table 82. Merck KGaA Product
Table 83. Merck KGaA Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 84. Merck KGaA Recent Development
Table 85. Thermo Fisher Scientific Company Details
Table 86. Thermo Fisher Scientific Business Overview
Table 87. Thermo Fisher Scientific Product
Table 88. Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 89. Thermo Fisher Scientific Recent Development
Table 90. Agilent Technologies Company Details
Table 91. Agilent Technologies Business Overview
Table 92. Agilent Technologies Product
Table 93. Agilent Technologies Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 94. Agilent Technologies Recent Development
Table 95. Takara Bio Company Details
Table 96. Takara Bio Business Overview
Table 97. Takara Bio Product
Table 98. Takara Bio Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 99. Takara Bio Recent Development
Table 100. Promega Corporation Company Details
Table 101. Promega Corporation Business Overview
Table 102. Promega Corporation Product
Table 103. Promega Corporation Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 104. Promega Corporation Recent Development
Table 105. Beijing TransGen Biotech Company Details
Table 106. Beijing TransGen Biotech Business Overview
Table 107. Beijing TransGen Biotech Product
Table 108. Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 109. Beijing TransGen Biotech Recent Development
Table 110. GeneScript Corporation Company Details
Table 111. GeneScript Corporation Business Overview
Table 112. GeneScript Corporation Product
Table 113. GeneScript Corporation Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 114. GeneScript Corporation Recent Development
Table 115. Yeastern Biotech Business Overview
Table 116. Yeastern Biotech Product
Table 117. Yeastern Biotech Company Details
Table 118. Yeastern Biotech Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 119. Yeastern Biotech Recent Development
Table 120. New England Biolabs Company Details
Table 121. New England Biolabs Business Overview
Table 122. New England Biolabs Product
Table 123. New England Biolabs Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 124. New England Biolabs Recent Development
Table 125. QIAGEN N.V. Company Details
Table 126. QIAGEN N.V. Business Overview
Table 127. QIAGEN N.V. Product
Table 128. QIAGEN N.V. Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 129. QIAGEN N.V. Recent Development
Table 130. OriGene Technologies Company Details
Table 131. OriGene Technologies Business Overview
Table 132. OriGene Technologies Product
Table 133. OriGene Technologies Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 134. OriGene Technologies Recent Development
Table 135. Lucigen Company Details
Table 136. Lucigen Business Overview
Table 137. Lucigen Product
Table 138. Lucigen Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 139. Lucigen Recent Development
Table 140. Zymo Research Company Details
Table 141. Zymo Research Business Overview
Table 142. Zymo Research Product
Table 143. Zymo Research Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 144. Zymo Research Recent Development
Table 145. Bio-Rad Laboratories Company Details
Table 146. Bio-Rad Laboratories Business Overview
Table 147. Bio-Rad Laboratories Product
Table 148. Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 149. Bio-Rad Laboratories Recent Development
Table 150. Bioline Company Details
Table 151. Bioline Business Overview
Table 152. Bioline Product
Table 153. Bioline Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 154. Bioline Recent Development
Table 155. Delphi Genetics Company Details
Table 156. Delphi Genetics Business Overview
Table 157. Delphi Genetics Product
Table 158. Delphi Genetics Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 159. Delphi Genetics Recent Development
Table 160. IBA GmBH Company Details
Table 161. IBA GmBH Business Overview
Table 162. IBA GmBH Product
Table 163. IBA GmBH Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 164. IBA GmBH Recent Development
Table 165. Cell Applications Company Details
Table 166. Cell Applications Business Overview
Table 167. Cell Applications Product
Table 168. Cell Applications Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 169. Cell Applications Recent Development
Table 170. BioDynamics Laboratory Company Details
Table 171. BioDynamics Laboratory Business Overview
Table 172. BioDynamics Laboratory Product
Table 173. BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 174. BioDynamics Laboratory Recent Development
Table 175. Scarab Genomics Company Details
Table 176. Scarab Genomics Business Overview
Table 177. Scarab Genomics Product
Table 178. Scarab Genomics Revenue in Electrocompetent Cells Business (2015-2020) (Million US$)
Table 179. Scarab Genomics Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Electrocompetent Cells Market Share by Type: 2020 VS 2026
Figure 2. Cloned Competent Cells Features
Figure 3. Agrobacterium tumefaciens Competent Cells Features
Figure 4. Expression Competent Cells Features
Figure 5. Global Electrocompetent Cells Market Share by Application: 2020 VS 2026
Figure 6. Subcloning & Routine Cloning Case Studies
Figure 7. Phage Display Library Construction Case Studies
Figure 8. Toxic/Unstable Dna Cloning Case Studies
Figure 9. High-Throughput Cloning Case Studies
Figure 10. Protein Expression Case Studies
Figure 11. Mutagenesis Case Studies
Figure 12. Single-Stranded Dna Production Case Studies
Figure 13. Bacmid creation Case Studies
Figure 14. Cre-lox recombination (PIR1/PIR2) Case Studies
Figure 15. Electrocompetent Cells Report Years Considered
Figure 16. Global Electrocompetent Cells Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Electrocompetent Cells Market Share by Regions: 2020 VS 2026
Figure 18. Global Electrocompetent Cells Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Electrocompetent Cells Market Share by Players in 2019
Figure 21. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Electrocompetent Cells as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Electrocompetent Cells Revenue in 2019
Figure 23. North America Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Electrocompetent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck KGaA Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 32. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Thermo Fisher Scientific Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 34. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Agilent Technologies Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 36. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Takara Bio Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 38. Promega Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Promega Corporation Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 40. Beijing TransGen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Beijing TransGen Biotech Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 42. GeneScript Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GeneScript Corporation Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 44. Yeastern Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Yeastern Biotech Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 46. New England Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. New England Biolabs Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 48. QIAGEN N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. QIAGEN N.V. Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 50. OriGene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. OriGene Technologies Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 52. Lucigen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Lucigen Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 54. Zymo Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Zymo Research Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 56. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 58. Bioline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Bioline Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 60. Delphi Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Delphi Genetics Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 62. IBA GmBH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. IBA GmBH Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 64. Cell Applications Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Cell Applications Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 66. BioDynamics Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. BioDynamics Laboratory Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 68. Scarab Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Scarab Genomics Revenue Growth Rate in Electrocompetent Cells Business (2015-2020)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed